C3 AI to Announce Financial Results for Fourth Quarter and Fiscal Year 2026 on June 3, 2026

C3 AI (NYSE: AI), the Enterprise AI application software company, today announced it will issue its financial results for the fiscal fourth quarter and full fiscal year, which ended April 30, 2026, following the close of the U.S. markets on Wednesday, June 3, 2026.

C3 AI will host a conference call and webcast to discuss the financial results. The conference call will begin at 2:00 p.m. PDT / 5:00 p.m. EDT on June 3, 2026. Analysts and investors may participate in the question-and-answer session.

Conference Call Details

Date: Wednesday, June 3, 2026
Time: 2:00 p.m. Pacific Standard Time

To access the conference call via a dial-in number and personalized PIN code, participants should register here: telephone registration .

To listen to the conference call via webcast, participants should register here: webcast registration .

Access to the conference call is also available on the C3 AI Investor Relations website events page. The audio replay will be available approximately two hours after its completion and will be accessible for 30 days on the C3 AI Investor Relations website.

About C3.ai, Inc.

C3 AI is the Enterprise AI application software company. C3 AI delivers a family of fully integrated products including the C3 Agentic AI Platform, an end-to-end platform for developing, deploying, and operating enterprise AI applications, C3 AI applications, a portfolio of industry-specific SaaS enterprise AI applications that enable the digital transformation of organizations globally, and C3 Generative AI, a suite of domain-specific generative AI offerings for the enterprise.

C3 AI Public Relations
Axicom
Mindy Nelson
830-214-4823
pr@c3.ai

Investor Relations
ir@c3.ai

News Provided by Business Wire via QuoteMedia

AI
The Conversation (0)
Homerun Resources Inc. Amends Terms of Previously Announced Financing

Homerun Resources Inc. Amends Terms of Previously Announced Financing

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to announce a slight amendment to the terms of the convertible security funding agreement (the "CFSA") previously announced on July 8, 2026 (the "Initial News Release"). The Initial News Release... Keep Reading...
Nine Mile Metals Announces Certified Assays of 3.49% Cu-Eq over 24.55 meters  in DDH WD-26-09

Nine Mile Metals Announces Certified Assays of 3.49% Cu-Eq over 24.55 meters in DDH WD-26-09

Including 4.03% Cu-Eq over 16.50m and 5.22% Cu-Eq over 6.50m Nine Mile Metals Ltd. (CSE: NINE,OTC:VMSXF) (OTCID: VMSXF) (FSE: KQ9) (the "Company" or "Nine Mile") is pleased to announce certified assay results for DDH WD-26-09, at the Wedge Mine in the Bathurst Mining Camp, New Brunswick. 3.49%... Keep Reading...
AmeriTrust Announces Second Quarter 2026 Financial Results

AmeriTrust Announces Second Quarter 2026 Financial Results

Funded lease contract growth accelerated in Q2 2026, with an increase of 205% in the value of contracts financed over Q1AmeriTrust Financial Technologies Inc. (TSXV: AMT,OTC:AMTFF) (OTCQB: AMTFF) (FSE: 1ZV) ("AmeriTrust", "AMT" or the "Company"), a fintech platform focused on automotive finance,... Keep Reading...
Aitenders Technologies Receives Final Approval from CSE and Commences Trading

Aitenders Technologies Receives Final Approval from CSE and Commences Trading

Aitenders Technologies Inc. (CSE: BIDS) (“Aitenders” or the “Company“), the developer of an end-to-end AI-powered platform for tender response and contract management purpose built for complex construction and infrastructure projects, is pleased to announce that the Company has received final... Keep Reading...
Solvonis Therapeutics (LSE:SVNS)

SVN-015 Advances into Further NIDA-Funded Studies Following Encouraging Initial Screening

Solvonis Therapeutics plc (LSE: SVNS), a late clinical-stage biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system ("CNS") disorders, is pleased to announce encouraging results from the initial in vitro cardiac ion-channel and broader... Keep Reading...

Interactive Chart

Latest Press Releases

Related News